ArticleMolecular cancer therapeutics2019

Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.

Jeanne M Quinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.